1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Biopharmaceuticals Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Biopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Biopharmaceuticals Market Regional Analysis
6.2 Europe Biopharmaceuticals Market Revenue 2020-2028 (US$ Billion)
6.3 Europe Biopharmaceuticals Market Forecast Analysis
7. Europe Biopharmaceuticals Market Analysis – by Product Type
7.1 Monoclonal Antibodies
- 7.1.1 Overview
- 7.1.2 Monoclonal Antibodies: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.2 Recombinant Vaccines
- 7.2.1 Overview
- 7.2.2 Recombinant Vaccines: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.3 Conventional Vaccines
- 7.3.1 Overview
- 7.3.2 Conventional Vaccines: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.4 Recombinant Growth Factors
- 7.4.1 Overview
- 7.4.2 Recombinant Growth Factors: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.5 Purified Proteins
- 7.5.1 Overview
- 7.5.2 Purified Proteins: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.6 Recombinant Proteins
- 7.6.1 Overview
- 7.6.2 Recombinant Proteins: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.7 Recombinant Hormones
- 7.7.1 Overview
- 7.7.2 Recombinant Hormones: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.8 Recombinant Enzymes
- 7.8.1 Overview
- 7.8.2 Recombinant Enzymes: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.9 Cell & Gene Therapies
- 7.9.1 Overview
- 7.9.2 Cell & Gene Therapies: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.10 Cytokines/Interferon/Interleukins
- 7.10.1 Overview
- 7.10.2 Cytokines/Interferon/Interleukins: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8. Europe Biopharmaceuticals Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.2 Inflammatory & Infectious Disease
- 8.2.1 Overview
- 8.2.2 Inflammatory & Infectious Disease: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.3 Autoimmune Disorders
- 8.3.1 Overview
- 8.3.2 Autoimmune Disorders: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.4 Metabolic Disorders
- 8.4.1 Overview
- 8.4.2 Metabolic Disorders: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.5 Hormonal Disorders & Growth Failure
- 8.5.1 Overview
- 8.5.2 Hormonal Disorders & Growth Failure: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.6 Cardiovascular Diseases
- 8.6.1 Overview
- 8.6.2 Cardiovascular Diseases: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.7 Neurological Diseases
- 8.7.1 Overview
- 8.7.2 Neurological Diseases: Europe Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
9. Europe Biopharmaceuticals Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Biopharmaceuticals Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.2.1.1 Europe Biopharmaceuticals Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.1.1 UK: Europe Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.1.2 UK: Europe Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.2.1 Germany: Europe Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.2.2 Germany: Europe Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.3 France:
Europe Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.3.1 France: Europe Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.3.2 France: Europe Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.4.1 Russia: Europe Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.4.2 Russia: Europe Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.5.1 Italy: Europe Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.5.2 Italy: Europe Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.6.1 Rest of Europe: Europe Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.6.2 Rest of Europe: Europe Biopharmaceuticals Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 AbbVie Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AGC Biologics AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Amgen Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bristol-Myers Squibb Co
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Eli Lilly and Co
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Johnson & Johnson
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Lonza Group AG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 WuXi Biologics Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Biopharmaceuticals Market
